Pharmacokinetics describes the quantitative relationship between administered drug dose and its concentration in plasma or at the effect site over time. Mastering these foundational principles is essential for anaesthesia practitioners to administer intravenous agents safely and effectively.
Distribution, Redistribution, and the Biophase
Most anaesthetic agents are lipophilic, allowing them to rapidly penetrate lipid membranes and diffuse into highly perfused cerebral tissue. This underlies the rapid induction seen with agents like propofol. The brief clinical duration of an initial bolus is governed predominantly by rapid redistribution from the central nervous system into blood and peripheral compartments during the first 4 minutes, rather than by systemic metabolism. Furthermore, the virtual effect-site compartment (biophase) accounts for clinical hysteresis—the temporal lag between peak blood concentration and peak drug response governed by ke0.
Hepatic Clearance and Extraction Dynamics
Hepatic clearance depends on three critical factors: hepatic blood flow (normally approximately 1.5 L/min), unbound plasma drug fraction, and intrinsic enzymatic capacity dominated by the cytochrome P450 superfamily. Drugs are classified into high, intermediate, and low hepatic extraction ratio categories. High extraction drugs such as propofol, ketamine, and fentanyl are perfusion-limited; their systemic clearance decreases significantly during low cardiac output states like shock. Conversely, low extraction drugs such as thiopental and diazepam are capacity-limited, relying strictly on intrinsic enzymatic activity and remaining largely unaffected by changes in blood flow.
Volume of Distribution and Pharmacokinetic Modelling
The apparent volume of distribution (Vd) is a mathematical parameter devoid of direct anatomical meaning that relates administered dose to initial plasma concentration. In a one-compartment framework, terminal elimination half-life is derived as t1/2 = 0.693 x (Vd / Cl), emphasizing that half-life is a dependent variable governed independently by both clearance and volume. Clinically, hypovolaemic patients exhibit a significantly elevated initial peak plasma concentration (C0) after standard induction doses, predisposing them to profound hypotension. Conversely, neonates possess an expanded extracellular fluid compartment, yielding a larger volume of distribution for hydrophilic drugs such as neuromuscular blockers.
- Pharmacokinetics quantitatively relates drug dose to concentration over time, governed largely by first-order kinetics and multi-compartment dynamics.
- Early emergence following an intravenous bolus of lipophilic anaesthetics is driven primarily by tissue redistribution rather than systemic clearance.
- Clearance of high-extraction drugs (e.g., propofol, fentanyl) is perfusion-limited and falls sharply in states of reduced cardiac output.
- Terminal elimination half-life cannot predict recovery after an infusion; context-sensitive decrement times dictate post-infusion drug washout.
- Hypovolaemia elevates initial peak plasma concentrations causing severe hypotension, whereas expanded neonatal extracellular volumes increase Vd for hydrophilic blockers.
Sources
- Miller's Basics of Anesthesia, page 31
- Miller's Basics of Anesthesia, page 33
- Miller's Basics of Anesthesia, page 36
- Miller's Basics of Anesthesia, page 37
- Clinical Anesthesia, page 650
- Clinical Anesthesia, page 663
- Clinical Anesthesia, page 665
- Clinical Anesthesia, page 666
- Clinical Anesthesia, page 668
- Clinical Anesthesia, page 675
- Clinical Anesthesia, page 676
- Clinical Anesthesia, page 688
- Clinical Anesthesia, page 703
- Clinical Anesthesia, page 709
- Smith and Aitkenhead's Textbook of Anaesthesia, page 16
- Smith and Aitkenhead's Textbook of Anaesthesia, page 17
Test yourself: 25 questions on this topic and many more →
Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.